Transcript of video
Dr. Michael Lanuti, MD, has superior skills in minimally invasive lung cancer and esophageal cancer surgical treatment. He combines clinical expertise with a top-notch research in cancer gene therapy. He cured my mother from a lung tumor. He did it via a 5 cm incision. Hello from Boston! We are with Dr. Michael Lanuti, MD. He is Associate Professor of Surgery at Harvard Medical School. He is Director of Thoracic Oncology for the Division of Thoracic Surgery at Massachusetts General Hospital in Boston. Dr. Lanuti obtained his MD from the University of Pennsylvania School of Medicine. He completed residency in surgery at the hospital of the University of Pennsylvania. He did research fellowship in thoracic oncology laboratory. Professor Michael Lanuti focused on gene therapy for lung cancer. Dr. Anton Titov, MD. He then finished Cardiothoracic Fellowship at the Massachusetts General Hospital in Boston. Dr. Michael Lanuti’s clinical interests are in lung cancer diagnosis and treatment, lung cancer molecular screening and gene therapy, minimally invasive lung cancer surgery, Visually Assisted Thoracoscopic Surgery, navigation bronchoscopy of lung nodules and endobronchial ultrasound for lung cancer staging and radiofrequency ablation for lung tumors. Dr. Michael Lanuti is also interested in diagnosis and treatment of esophageal cancer, Barrett’s esophagus, mediastinal tumors and germ cell tumors and in surgical treatment of myasthenia gravis. Dr. Michael Lanuti, MD authored and co-authored 110 publications in peer-reviewed international medical journals and presented at numerous international medical conferences. He wrote several book chapters on lung cancer diagnosis and treatment. Dr. Anton Titov, MD. Dr. Lanuti, hello and welcome! Thank you! Lung cancer treatment options depend on correct staging of the tumor. So it’s a very important step after a patient is diagnosed with or suspected to have lung cancer. Dr. Michael Lanuti, MD. How do you stage patients with lung cancer?